This website is intended for Canadian residents only. The site provides selected information about the Respimat device. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and the content on this site reflects the terms of marketing authorization in Canada. The website is not intended to be a substitute for the advice of a healthcare professional, or a recommendation for any particular treatment plan. It is important that consumers rely on the advice of a healthcare professional who can apply clinical judgement for the specific conditions of each individual patient.
Personal information means any information about an identifiable individual. The type of personal information that we collect from you include:
We will only collect, use, and disclose your personal information for specific purposes that are identified to you. We will not use your personal information for the purposes other than those identified and we will not keep your personal information for longer than is necessary to fulfill the purpose(s) of collection or as required by law. Personal information that is no longer required to fulfil an identified purpose will be erased, destroyed or made anonymous except as may be provided by law.
In some cases, we may automatically collect your personal information when you use our website. For example, your IP address or cookies contain information that could make you identifiable. In such a case, your use of our website means that you have provided your implied consent to the collection of that personal information.
The personal data and uses specified under sections “What Personal Information is Collected” and “How your Personal Information is Used” may be shared with the following third-party companies: Boehringer Ingelheim (Canada) Ltd. related companies; Omnicom Health Group Inc. and Rackspace Inc.
Should there be a privacy breach relating to the personal information that you provided to us, we will make an assessment of whether this breach creates a real risk of significant harm to you. If so, we will notify you and suggest steps to take to reduce to the risk of harm, if possible.
Boehringer Ingelheim (Canada) Ltd./Ltée. uses a variety of measures to protect the personal information it collects, including physical, organizational and technological measures. Any personal information will be treated by Boehringer Ingelheim (Canada) Ltd./Ltée. in accordance with the Personal Information Protection and Electronic Documents Act (PIPEDA) and applicable privacy laws. No data transmission over the internet or data storage system can be guaranteed as 100% secure. Any transmission is at your own risk.
Please report any adverse events associated with Boehringer Ingelheim (Canada) Ltd./Ltée products to Pharmacovigilance by calling 1-800-263-5103 Ext 87233 (U-SAFE).
These Legal Notices pertain to Boehringer Ingelheim (Canada) Ltd./Ltée.
Copyright Information: Copyright © 2019 Boehringer Ingelheim (Canada) Ltd./Ltée.
All rights reserved.
This website is provided "as is" without warranty of any kind, either expressed or implied, including, but not limited to, the implied warranties of merchantability, fitness for a particular purpose, or non-infringement.
Boehringer Ingelheim (Canada) Ltd./Ltée. has used reasonable efforts to include accurate and up-to-date information within this website, however, material may become out of date over time. Boehringer Ingelheim (Canada) Ltd./Ltée. makes no warranties or representations as to its accuracy.
Neither Boehringer Ingelheim (Canada) Ltd./Ltée., its parent company or other affiliated companies, nor any party involved in creating, producing or delivering this website and information contained within, shall be liable for any direct, incidental, consequential, indirect or punitive damages arising out of access to, use of, or inability to use this website or any errors or omissions in its content.
This website is intended for Canadian residents only. The site provides selected information available about a range of disease topics. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and the content on this site reflects the terms of marketing authorization in Canada. This information is not intended to be a substitute for the advice of a healthcare professional, or a recommendation for any particular treatment plan. It is important that consumers rely on the advice of a healthcare professional who can apply clinical judgement for the specific conditions of each individual patient.
Boehringer Ingelheim (Canada) Ltd./Ltée. cannot recommend the use of products outside the Canadian approved Product Monograph.
Unless, otherwise indicated, all product names, whether or not appearing in large print or with the trademark symbol, are trademarks of Boehringer Ingelheim, its affiliates, related companies, its licensors or joint venture partners, used under license. The use of these trademarks or any other materials contained in this website, except as permitted, is expressly prohibited and may be in violation of copyright law, trademark law, or other regulations and statutes.
The content found within this website is for educational purposes only. The material that is available for you to view and download is for your exclusive use and should not be redistributed in any way.
Certain links on this website lead to resources located on servers maintained by third parties over whom Boehringer Ingelheim (Canada) Ltd./Ltée. has no control. As such, Boehringer Ingelheim (Canada) Ltd./Ltée. makes no representation as to the accuracy or any other aspect of the information contained on such servers.
Boehringer Ingelheim (Canada) Ltd./Ltée. social media channels are managed from our Canadian head office in Burlington, Ontario, and are intended to provide information and content about our local business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and country-specific social media content on this topic may have been issued in the countries where we do business.